Development of a nuclear morphometric signature for prostate cancer risk in negative biopsies.
about
Epithelial-mesenchymal transition in prostate cancer is associated with quantifiable changes in nuclear structure.Nuclear Shape and Architecture in Benign Fields Predict Biochemical Recurrence in Prostate Cancer Patients Following Radical Prostatectomy: Preliminary Findings.Machine Learning for Nuclear Mechano-Morphometric Biomarkers in Cancer Diagnosis.Evolution: Back to the future to understand and control prostate cancer.Advances in the computational and molecular understanding of the prostate cancer cell nucleus
P2860
Development of a nuclear morphometric signature for prostate cancer risk in negative biopsies.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Development of a nuclear morph ...... cer risk in negative biopsies.
@ast
Development of a nuclear morph ...... cer risk in negative biopsies.
@en
Development of a nuclear morph ...... cer risk in negative biopsies.
@nl
type
label
Development of a nuclear morph ...... cer risk in negative biopsies.
@ast
Development of a nuclear morph ...... cer risk in negative biopsies.
@en
Development of a nuclear morph ...... cer risk in negative biopsies.
@nl
prefLabel
Development of a nuclear morph ...... cer risk in negative biopsies.
@ast
Development of a nuclear morph ...... cer risk in negative biopsies.
@en
Development of a nuclear morph ...... cer risk in negative biopsies.
@nl
P2093
P2860
P1433
P1476
Development of a nuclear morph ...... cer risk in negative biopsies.
@en
P2093
Anup Amatya
Erika Enk Rueter
Mahesh Mohnani
Peter H Gann
Ryan Deaton
Viju Ananthanarayanan
Yirong Yang
P2860
P304
P356
10.1371/JOURNAL.PONE.0069457
P407
P577
2013-07-26T00:00:00Z